Abstract:Biopharmaceuticals have emerged as powerful therapeutic agents, revolutionizing the treatment landscape for various diseases, including cancer, infectious diseases, autoimmune and genetic disorders. These biotherapeutics pave the way for precision medicine with their unique and targeted capabilities. The production of high-quality biologics entails intricate manufacturing processes, including cell culture, fermentation, purification, and formulation, necessitating specialized facilities and expertise. These complex processes are subject to rigorous regulatory oversight to evaluate the safety, efficacy, and quality of biotherapeutics prior to clinical approval. Consequently, these drugs undergo extensive purification unit operations to achieve high purity by effectively removing impurities and contaminants. The field of personalized precision medicine necessitates the development of novel and highly efficient technologies. Microfluidic technology addresses unmet needs by enabling precise and compact separation, allowing rapid, integrated and continuous purification modules. Moreover, the integration of intelligent biomanufacturing systems with miniaturized devices presents an opportunity to significantly enhance the robustness of complex downstream processing of biopharmaceuticals, with the benefits of automation and advanced control. This allows seamless data exchange, real-time monitoring, and synchronization of purification steps, leading to improved process efficiency, data management, and decision-making. Integrating autonomous systems into biopharmaceutical purification ensures adherence to regulatory standards, such as good manufacturing practice (GMP), positioning the industry to effectively address emerging market demands for personalized precision nano-medicines. This perspective review will emphasize on the significance, challenges, and prospects associated with the adoption of continuous, integrated, and intelligent methodologies in small-scale downstream processing for various types of biologics. By utilizing microfluidic technology and intelligent systems, purification processes can be enhanced for increased efficiency, cost-effectiveness, and regulatory compliance, shaping the future of biopharmaceutical production and enabling the development of personalized and targeted therapies.

On demand biomanufacturing through synthetic biology approach

Cell-free Protein Synthesis Enabled Rapid Prototyping for Metabolic Engineering and Synthetic Biology

Programming Living Sensors for Environment, Health and Biomanufacturing

Cell-free Synthetic Biology: an Emerging Strategy Torevolutionize the Biomedical Industry

Cell-Free Synthesis: Expediting Biomanufacturing of Chemical and Biological Molecules

Developing the biofacility of the future based on continuous processing and single-use technology

On-demand manufacturing of clinical-quality biopharmaceuticals

Towards next-generation model microorganism chassis for biomanufacturing

Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals

Advances in bioprocessing for efficient bio manufacture

Advances in cell-free protein synthesis

Applications, challenges, and needs for employing synthetic biology beyond the lab

Cell factory-based milk protein biomanufacturing: Advances and perspectives

Synthetic biology advances and applications in the biotechnology industry: a perspective

An in Vitro Synthetic Biology Platform for Emerging Industrial Biomanufacturing: Bottom-up Pathway Design

Applications of synthetic biology in medical and pharmaceutical fields

From Discovery to Production: Challenges and Novel Methodologies for Next Generation Biomanufacturing

[Progress of cell-free protein synthesis system and its applications in pharmaceutical engineering - A review].

Cell-free Synthetic Biotechnology-Multi-enzyme Catalysis and Biosynthesis

Biological Materials: The Next Frontier for Cell-Free Synthetic Biology

Biopharmaceutical Protein Production by Saccharomyces Cerevisiae: Current State and Future Prospects